Realtime | Geld | Brief | Zeit |
---|---|---|---|
15,100 | 15,450 | 20:54 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.06. | PIHLAJALINNA OYJ: Pihlajalinna starts repurchasing own shares | 2 | Cision News | ||
30.05. | Pihlajalinna Oyj: Inside information, profit warning: Pihlajalinna updates its guidance for 2025 | 192 | GlobeNewswire (Europe) | Pihlajalinna Plc Inside Information 30 May 2025 at 11:00 a.m.
Inside information, profit warning: Pihlajalinna updates its guidance for 2025
Pihlajalinna... ► Artikel lesen | |
06.05. | PIHLAJALINNA OYJ: Transfer of Pihlajalinna's own shares | 1 | Cision News | ||
30.04. | Pihlajalinna Oyj: Pihlajalinna's medium-term strategic targets | 146 | GlobeNewswire (Europe) | Pihlajalinna Plc Stock Exchange Release 30 April 2025 at 8:30 a.m.
Pihlajalinna's medium-term strategic targets
Pihlajalinna Plc's Board of Directors has approved the company's medium-term... ► Artikel lesen | |
30.04. | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-31 March 2025: Pihlajalinna's profitability improved, steady revenue growth in Private Healthcare Services continued | 139 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 30 April 2025 at 8:00 a.m.
Pihlajalinna Interim Report 1 January-31 March 2025
Pihlajalinna's profitability improved... ► Artikel lesen | |
25.04. | Dividendenbekanntmachungen (25.04.2025) | 15.399 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABG SUNDAL COLLIER HOLDING ASA NO0003021909 0,5 NOK 0,0422 EUR ABN AMRO BANK NV NL0011540547 - 0,75 EUR ABSA GROUP LIMITED ADR US00400T1025 0... ► Artikel lesen | |
PIHLAJALINNA Aktie jetzt für 0€ handeln | |||||
24.04. | Pihlajalinna Oyj: Resolutions of the Annual General Meeting and the constitutive meeting of the Board of Directors of Pihlajalinna Plc | 202 | GlobeNewswire (Europe) | Pihlajalinna Plc Stock Exchange Release 24 April 2025 at 2:00 p.m.
Resolutions of the Annual General Meeting and the constitutive meeting of the Board of Directors... ► Artikel lesen | |
16.04. | PIHLAJALINNA OYJ: Pihlajalinna Plc publishes Intermin Report for January 1-March 31, 2025, on Wednesday, 30 April 2025 | 1 | Cision News | ||
01.04. | PIHLAJALINNA OYJ: Pihlajalinna has published the 2024 Annual Report | 1 | Cision News | ||
25.03. | PIHLAJALINNA OYJ: Invitation to Pihlajalinna's Capital Markets Day on 9 May 2025 | 1 | Cision News | ||
19.03. | PIHLAJALINNA OYJ: Pihlajalinna Plc: Notice to Annual General Meeting | 1 | Cision News | ||
14.03. | PIHLAJALINNA OYJ: Pihlajalinna's disposal of own shares based on the share-based incentive programme | 2 | Cision News | ||
12.02. | Pihlajalinna Oyj: Pihlajalinna Financial Statements Release 1 January-31 December 2024: Strong organic growth, operating cash flow and profitability development in 2024 | 127 | GlobeNewswire (Europe) | Pihlajalinna Plc Financial Statements Release 12 February 2025 at 8:00 a.m.
Pihlajalinna Financial Statements Release 1 January-31 December 2024
Strong organic growth, operating cash flow... ► Artikel lesen | |
28.01. | PIHLAJALINNA OYJ: Pihlajalinna Plc publishes Financial Statements Release 2024 on Wednesday, 12 February 2025 | 1 | Cision News | ||
07.11.24 | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-30 September 2024: Solid development in organic growth and profitability | 119 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 7 November 2024 at 8:00 a.m.
Pihlajalinna Interim Report 1 January-30 September 2024
Solid development in organic... ► Artikel lesen | |
30.10.24 | Pihlajalinna Oyj: Insider information, positive profit warning: Pihlajalinna upgrades its profitability guidance for 2024 and provides preliminary information on revenue and profitability for the third quarter of 2024 | 150 | GlobeNewswire (Europe) | Pihlajalinna Plc Insider Information 30 October 2024 at 8:00 a.m.
Insider information, positive profit warning: Pihlajalinna upgrades its profitability guidance... ► Artikel lesen | |
09.08.24 | Pihlajalinna Oyj: Pihlajalinna Half Year Financial Report 1 January-30 June 2024: Profitability and customer satisfaction continued to improve | 180 | GlobeNewswire (Europe) | Pihlajalinna Plc Half Year Financial Report 9 August 2024 at 8:00 a.m.
Pihlajalinna Half Year Financial Report 1 January-30 June 2024
Profitability and customer... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BICO GROUP | 3,266 | +4,88 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
EUROFINS SCIENTIFIC | 63,96 | +1,36 % | Eurofins H1 Net Income Rises | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Eurofins reported that its first half net profit to owners of the company and hybrid capital investors increased to 247 million euros from 221 million euros... ► Artikel lesen | |
PING AN HEALTHCARE | 1,005 | -0,84 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
EMEIS | 10,840 | +1,40 % | emeis S.A.: emeis: Half-Year Review (H1 2025) of the Liquidity Agreement Entered Into With Natixis ODDO BHF | Regulatory News:
Under the liquidity agreement entrusted by emeis S.A. (the "Company") (Paris:EMEIS) to Natixis ODDO BHF, the following resources were recorded in the dedicated liquidity account... ► Artikel lesen | |
CYTOSORBENTS | 0,880 | +2,80 % | A Glimpse Into The Expert Outlook On CytoSorbents Through 5 Analysts | ||
CLARIANE | 4,798 | +1,27 % | Bernstein initiates Clariane at "outperform" after €1.5 bln recovery plan | ||
ICON | 142,95 | +4,04 % | ICON plc: ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report | ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1... ► Artikel lesen | |
ARJO | 3,050 | -0,07 % | Arjo AB: Niclas Sjöswärd leaving the position as interim President and CEO of Arjo | Niclas Sjöswärd has informed the Board of Directors of his decision to leave Arjo for a position outside the Group. Niclas will continue in his role as interim President & CEO until mid-January 2026.... ► Artikel lesen | |
M3 INC | 10,700 | +0,94 % | M3-Aktie leicht im Plus (10,90 €) | An der Börse liegt die M3-Aktie zur Stunde im Plus. Der jüngste Kurs betrug 10,90 Euro. An der Börse liegt die Aktie von M3 gegenwärtig im Plus. Die Aktie legte um 0,4 Euro zu. Am Aktienmarkt zahlen... ► Artikel lesen | |
DYNAVOX GROUP | 11,210 | +1,91 % | Dynavox Group AB: Dynavox Group Interim Report second quarter 2025 | Dynavox Group AB (publ) today announced its results for the second quarter 2025.
Comment from the Dynavox Group CEO Fredrik Ruben:
Dynavox Group delivered another quarter of exceptional growth and... ► Artikel lesen | |
NYXOAH | 6,590 | -0,15 % | Nyxoah Reports First Quarter Financial and Operating Results | REGULATED INFORMATION Nyxoah Reports First Quarter Financial and Operating Results Company On Track for Anticipated PMA Approval in the Second Quarter of 2025 Successfully Completed FDA Validation... ► Artikel lesen | |
INTERPACE BIOSCIENCES | 0,735 | 0,00 % | Interpace Biosciences, Inc.: Effective May 2, 2025, Interpace Diagnostics Will No Longer Accept Specimens for PancraGEN, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk | Interpace Expects to Remain Profitable as a Thyroid-focused Business PARSIPPANY, NJ, April 24, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, ("Interpace"... ► Artikel lesen | |
NIAGEN BIOSCIENCE | 8,200 | +1,86 % | Niagen Bioscience, Inc: Niagen Bioscience to Participate at the Roth 15th Annual London Conference | Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces... ► Artikel lesen | |
NANOSONICS | 2,060 | 0,00 % | NANOSONICS LIMITED: Becoming a substantial holder | ||
CHINA MEDICAL SYSTEM | 1,490 | +6,43 % | China Medical System Holdings Limited: CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets | SINGAPORE, July 21, 2025 - (ACN Newswire) - On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited ("CMS" or the "Group") on the Main Board of the Singapore... ► Artikel lesen |